NUCLEATE BIO INC
Income Statement
Fiscal Year Start:
Jan 1
Revenues in 2024
$2,418,388
Program Services
87%
Contributions
11%
Other
<1%
Investments
<1%
Government Grants
0%
Fundraising Events
0%
Membership Dues
0%
Expenses in 2024
$2,204,873
Other
44%
Fees to Service Providers
25%
Salaries & Benefits
19%
Offices, Occupancy & IT
7%
Grants
4%
Advertising & Promotion
<1%
Benefits to Members
0%
Interest
0%
Depreciation
0%
Revenues
2023
2024
Change
Contributions
$2,552,896
$276,246
-89%
Government Grants
$0
$0
-
Fundraising Events
$0
$0
-
Program Services
$0
$2,107,885
-
Membership Dues
$0
$0
-
Investments
$0
$14,062
-
Other
$21,127
$20,195
-4%
Total Revenues
$2,574,023
$2,418,388
-6%
Expenses
2023
2024
Change
Grants
$59,950
$97,610
+63%
Benefits to Members
$0
$0
-
Salaries & Benefits
$200,661
$429,491
+114%
Fees to Service Providers
$426,488
$551,201
+29%
Advertising & Promotion
$33,955
$9,460
-72%
Offices, Occupancy & IT
$141,505
$148,338
+5%
Interest
$0
$0
-
Depreciation
$0
$0
-
Other
$1,517,062
$968,773
-36%
Total Expenses
$2,379,621
$2,204,873
-7%
Net income
2023
2024
Change
Net income
+$194,402
+$213,515
+10%
Functional Expenses
Summary
2023
2024
Change
Program
$2,239,187
$1,941,734
-13%
Admin
$140,434
$263,139
+87%
Fundraising
$0
$0
-
Total Expenses
$2,379,621
$2,204,873
-7%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)